Coronavirus
India’s Bharat Biotech gets official approval to test nasal COVID-19 shot as booster
India vaccine manufacturer Bharat Biotech on Wednesday got ‘in principle’ approval from the country’s drug regulator to test nasal COVID-19 vaccine as a booster shot.
The drug regulator DCGI granted approval to Hyderabad-based Bharat Biotech for conducting late-stage trials of its nasal COVID-19 vaccine to be used as a booster shot, according to news agency ANI.
Read the latest updates in our dedicated coronavirus section.
Meanwhile, India on Wednesday reported 58,097 new COVID-19 cases, 124 deaths in last 24 hours. The government said that the country has reported 2,135 omicron cases so far.
For the latest headlines, follow our Google News channel online or via the app.
Read more: India launches drive to vaccinate children before a feared omicron surge
Also Read
-
India launches drive to vaccinate children before a feared omicron surge
India started vaccinating children aged 15 to 18 against the coronavirus on Monday as it quickly expands its inoculation effort to cover the world’s ... Coronavirus -
India’s daily COVID-19 cases rise by 22,775
India reported on Saturday 22,775 new COVID-19 infections over the past 24 hours, pushed up by a growing number of omicron variant cases, data from ... World News -
India to vaccinate teens, provide booster for health workers
India will begin vaccinating teenagers from the ages of 15 to 18 from Jan. 3 and also administer booster vaccine doses for health-care workers a week ... Coronavirus -
India reports highest COVID-19 fatalities since July as states update tallies
India on Sunday reported its highest single-day COVID-19 deaths since July after two states revised their death tolls.The eastern state of Bihar added ... Coronavirus
